Sponsor or institution
Clinical trials and research at Proteogenomics Research Instit/sys/ Med
As of November 12, 2026, Find a Trial lists 5 NIH-funded research projects at this institution, with $4.2 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5NIH research projects
NIH-funded research (5)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Delivering anti-fibrotic treatment directly to lung cells to reverse fibrosis
Aimed at delivering antifibrotic drugs straight to lung tissue to help reverse scarring in patients with idiopathic pulmonary fibrosis.
-
Bispecific immunotherapy delivery system for lung diseases
A new dual-precision delivery method is being developed to get immune therapies directly into the lungs to treat ARDS and related conditions.
-
Delivering anti‑scarring drugs directly to the lungs' scar‑forming cells
This project is developing a way to send tiny, targeted doses of anti‑scarring therapy straight to the lungs to help people with idiopathic pulmonary fibrosis (IPF) and other lung scarring conditions.
-
New drug delivery system for treating lung diseases
This study is testing a new way to deliver medicine directly to the lungs to help people with lung diseases like Acute Respiratory Distress Syndrome (ARDS), aiming to make treatments work better while causing fewer side effects.
-
Targeting lung cells to reverse fibrosis
This study is testing a new way to deliver medicine directly to the lungs to help people with lung scarring from conditions like idiopathic pulmonary fibrosis, aiming to reduce the damage and promote healing.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.